Tetraphase Pharmaceuticals, Inc. (TTPH) Loss Form

See If You Qualify For Monetary Reward

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit.

Submit Transaction Detail Now (Optional)

- OR -

    This submission does not create an attorney-client relationship. If we believe that you might be an appropriate lead plaintiff, we will contact you to discuss whether to establish an attorney-client relationship.

    FAX: 212-363-7171

    TOLL FREE: 877-363-5972

    Levi & Korsinsky announces the commencement of a class action in the United States District Court for the Southern District of New York on behalf of Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) shareholders who purchased shares pursuant to the July 2017 secondary public offering and/or between March 8, 2017 and February 13, 2018.

    If you suffered a loss in Tetraphase Pharmaceuticals you have until September 25, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.